View original post here: IN8bio Appoints Dr. Corinne Epperly to Board of Directors
View original post here: IN8bio Appoints Dr. Corinne Epperly to Board of Directors
Originally posted here: Korro Announces Selection of its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
See the original post here: Vittoria Biotherapeutics Announces FDA Clearance of IND Application for VIPER-101 to Treat T-Cell Lymphoma
More: Immutep Receives A$2.6 million R&D Tax Incentive from French Government
Read more here: Accelus Announces Renewed Focus on Pioneering Minimally Invasive Outpatient Procedures with Its Advanced Adaptive Geometry Technology
Excerpt from: Cogent Biosciences Presents New Preclinical Data Highlighting Potential Best-in-Class Potency and Selectivity of ErbB2 and PI3Kα inhibitor programs...
More: Ryvu Therapeutics Presents Data on RVU120 at the San Antonio Breast Cancer Symposium 2023
Link: New York Blood Center Enterprises Makes Investment to Advance Next-Generation Red Blood Cell Research
Read the original: SciSparc Provides Updates Regarding the Non-Binding Letter of Intent to Acquire Leading Vehicle Importer Company in Israel
Recent Comments